Forecast to Publish a Notice of Funding Opportunity for Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed)
National Institutes of Health
Classification and identifiers
- Solicitation number
- FOR-CA-25-087
- Assistance listing (CFDA)
- 93.394
Amount
Amount not published by the funder
Who can apply
About this opportunity
The National Cancer Institute (NCI), with National Human Genome Research Institute (NHGRI) and National Institute of Biomedical Imaging and Bioengineering (NIBIB), intends to publish a Notice of Funding Opportunity (NOFO) to support early-career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses. Both small businesses and universities are drivers of technological innovation in the United States (U.S.), often working together to advance innovative ideas into products that can benefit the U.S. population. While most NIH funding supports basic research in university laboratories, the NIH also supports innovative technology development in U.S. small businesses through its SBIR and...
Related opportunities
- Notice of Intent to Publish a Funding Opportunity Announcement for Trailblazer Award for New and Early-Stage Investigators (R21 Clinical Trial Optional)National Institutes of Health
- Forecast to Publish a Notice of Funding Opportunity for Academic Career Excellence (ACE) Award (K32 - Clinical Trial Required)National Institutes of Health
- Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)National Institutes of Health
- Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)National Institutes of Health
- Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)National Institutes of HealthCloses Jul 2029
- Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)National Institutes of Health